Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
WRNIP1
|
ENSG00000124535.11 | WRN helicase interacting protein 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
WRNIP1 | hg19_v2_chr6_+_2765595_2765797 | 0.23 | 2.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_128431444 | 7.88 |
ENST00000459946.1
ENST00000378685.4 ENST00000464832.1 ENST00000472049.1 ENST00000488925.1 |
CCDC136
|
coiled-coil domain containing 136 |
chr3_-_195538728 | 7.08 |
ENST00000349607.4
ENST00000346145.4 |
MUC4
|
mucin 4, cell surface associated |
chr4_-_107957454 | 6.95 |
ENST00000285311.3
|
DKK2
|
dickkopf WNT signaling pathway inhibitor 2 |
chr6_+_1389989 | 6.63 |
ENST00000259806.1
|
FOXF2
|
forkhead box F2 |
chr11_-_111784005 | 6.46 |
ENST00000527899.1
|
CRYAB
|
crystallin, alpha B |
chr19_-_35626104 | 6.21 |
ENST00000310123.3
ENST00000392225.3 |
LGI4
|
leucine-rich repeat LGI family, member 4 |
chr4_-_90758227 | 6.10 |
ENST00000506691.1
ENST00000394986.1 ENST00000506244.1 ENST00000394989.2 ENST00000394991.3 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chrX_+_101380642 | 6.01 |
ENST00000372780.1
ENST00000329035.2 |
TCEAL2
|
transcription elongation factor A (SII)-like 2 |
chr16_+_29911864 | 5.88 |
ENST00000308748.5
|
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
chr11_-_111783595 | 5.83 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
chr3_-_195538760 | 5.76 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
chr19_+_18723660 | 5.75 |
ENST00000262817.3
|
TMEM59L
|
transmembrane protein 59-like |
chr12_-_50298000 | 5.73 |
ENST00000550635.2
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
chr11_-_111783919 | 5.73 |
ENST00000531198.1
ENST00000533879.1 |
CRYAB
|
crystallin, alpha B |
chr7_-_100253993 | 5.52 |
ENST00000461605.1
ENST00000160382.5 |
ACTL6B
|
actin-like 6B |
chr16_+_4845379 | 5.43 |
ENST00000588606.1
ENST00000586005.1 |
SMIM22
|
small integral membrane protein 22 |
chr1_+_159175201 | 5.43 |
ENST00000368121.2
|
DARC
|
Duffy blood group, atypical chemokine receptor |
chr12_+_121088291 | 5.35 |
ENST00000351200.2
|
CABP1
|
calcium binding protein 1 |
chr19_+_11650709 | 5.35 |
ENST00000586059.1
|
CNN1
|
calponin 1, basic, smooth muscle |
chr2_-_220173685 | 5.28 |
ENST00000423636.2
ENST00000442029.1 ENST00000412847.1 |
PTPRN
|
protein tyrosine phosphatase, receptor type, N |
chr19_-_47975106 | 5.22 |
ENST00000539381.1
ENST00000594353.1 ENST00000542837.1 |
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chrX_-_13835461 | 5.03 |
ENST00000316715.4
ENST00000356942.5 |
GPM6B
|
glycoprotein M6B |
chr9_-_35691017 | 5.02 |
ENST00000378292.3
|
TPM2
|
tropomyosin 2 (beta) |
chr1_+_111889212 | 4.97 |
ENST00000369737.4
|
PIFO
|
primary cilia formation |
chr19_-_7936344 | 4.90 |
ENST00000599142.1
|
CTD-3193O13.9
|
Protein FLJ22184 |
chr17_-_41984835 | 4.90 |
ENST00000520406.1
ENST00000518478.1 ENST00000522172.1 ENST00000461854.1 ENST00000521178.1 ENST00000520305.1 ENST00000523501.1 ENST00000520241.1 |
MPP2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr11_-_12030746 | 4.89 |
ENST00000533813.1
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chr21_+_27011899 | 4.84 |
ENST00000425221.2
|
JAM2
|
junctional adhesion molecule 2 |
chr20_+_53092123 | 4.79 |
ENST00000262593.5
|
DOK5
|
docking protein 5 |
chr17_+_32612687 | 4.78 |
ENST00000305869.3
|
CCL11
|
chemokine (C-C motif) ligand 11 |
chr3_+_75955817 | 4.72 |
ENST00000487694.3
ENST00000602589.1 |
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
chr20_+_5892037 | 4.71 |
ENST00000378961.4
|
CHGB
|
chromogranin B (secretogranin 1) |
chr19_-_49149553 | 4.71 |
ENST00000084798.4
|
CA11
|
carbonic anhydrase XI |
chr14_-_105420241 | 4.66 |
ENST00000557457.1
|
AHNAK2
|
AHNAK nucleoprotein 2 |
chr14_+_79746249 | 4.63 |
ENST00000428277.2
|
NRXN3
|
neurexin 3 |
chr3_+_111717511 | 4.62 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
chr2_-_99485825 | 4.57 |
ENST00000423771.1
|
KIAA1211L
|
KIAA1211-like |
chr19_-_11591848 | 4.54 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
chr5_+_175223313 | 4.44 |
ENST00000359546.4
|
CPLX2
|
complexin 2 |
chr2_-_230579185 | 4.39 |
ENST00000341772.4
|
DNER
|
delta/notch-like EGF repeat containing |
chr16_+_55522536 | 4.38 |
ENST00000570283.1
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chrX_-_13835398 | 4.36 |
ENST00000475307.1
|
GPM6B
|
glycoprotein M6B |
chr5_+_152870106 | 4.34 |
ENST00000285900.5
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1 |
chr1_+_159174701 | 4.33 |
ENST00000435307.1
|
DARC
|
Duffy blood group, atypical chemokine receptor |
chr19_-_35625765 | 4.31 |
ENST00000591633.1
|
LGI4
|
leucine-rich repeat LGI family, member 4 |
chr6_-_34524049 | 4.28 |
ENST00000374037.3
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
chr22_+_35936915 | 4.26 |
ENST00000216127.4
|
RASD2
|
RASD family, member 2 |
chr19_-_49945617 | 4.26 |
ENST00000600601.1
ENST00000543531.1 |
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
chr1_+_204797749 | 4.24 |
ENST00000367172.4
ENST00000367171.4 ENST00000367170.4 ENST00000338515.6 ENST00000339876.6 ENST00000338586.6 ENST00000539706.1 ENST00000360049.4 ENST00000367169.4 ENST00000446412.1 ENST00000403080.1 |
NFASC
|
neurofascin |
chr11_-_790060 | 4.22 |
ENST00000330106.4
|
CEND1
|
cell cycle exit and neuronal differentiation 1 |
chr7_+_153749732 | 4.22 |
ENST00000377770.3
|
DPP6
|
dipeptidyl-peptidase 6 |
chr20_+_24449821 | 4.22 |
ENST00000376862.3
|
SYNDIG1
|
synapse differentiation inducing 1 |
chr16_+_80574854 | 4.21 |
ENST00000305904.6
ENST00000568035.1 |
DYNLRB2
|
dynein, light chain, roadblock-type 2 |
chr12_+_13044787 | 4.20 |
ENST00000534831.1
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A |
chr17_-_41985096 | 4.18 |
ENST00000269095.4
ENST00000523220.1 |
MPP2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr4_-_168155730 | 4.15 |
ENST00000502330.1
ENST00000357154.3 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr8_+_80523321 | 4.14 |
ENST00000518111.1
|
STMN2
|
stathmin-like 2 |
chr6_-_34524093 | 4.06 |
ENST00000544425.1
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
chr19_+_51152702 | 4.04 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
chr6_+_17393888 | 3.96 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr19_-_51529849 | 3.96 |
ENST00000600362.1
ENST00000453757.3 ENST00000601671.1 |
KLK11
|
kallikrein-related peptidase 11 |
chr5_+_152870287 | 3.93 |
ENST00000340592.5
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1 |
chr19_+_54412517 | 3.92 |
ENST00000391767.1
|
CACNG7
|
calcium channel, voltage-dependent, gamma subunit 7 |
chr3_-_116164306 | 3.90 |
ENST00000490035.2
|
LSAMP
|
limbic system-associated membrane protein |
chr14_+_42076765 | 3.89 |
ENST00000298119.4
|
LRFN5
|
leucine rich repeat and fibronectin type III domain containing 5 |
chr12_+_119616447 | 3.89 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
chr11_-_12030629 | 3.87 |
ENST00000396505.2
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chr11_-_111781610 | 3.84 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
chr6_+_17393839 | 3.84 |
ENST00000489374.1
ENST00000378990.2 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr12_-_77272765 | 3.81 |
ENST00000547435.1
ENST00000552330.1 ENST00000546966.1 ENST00000311083.5 |
CSRP2
|
cysteine and glycine-rich protein 2 |
chr6_-_30899924 | 3.80 |
ENST00000359086.3
|
SFTA2
|
surfactant associated 2 |
chr7_+_121513374 | 3.78 |
ENST00000449182.1
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
chr20_+_5892147 | 3.78 |
ENST00000455042.1
|
CHGB
|
chromogranin B (secretogranin 1) |
chr10_+_48355024 | 3.78 |
ENST00000395702.2
ENST00000442001.1 ENST00000433077.1 ENST00000436850.1 ENST00000494156.1 ENST00000586537.1 |
ZNF488
|
zinc finger protein 488 |
chr8_+_80523962 | 3.77 |
ENST00000518491.1
|
STMN2
|
stathmin-like 2 |
chr9_-_34381536 | 3.76 |
ENST00000379126.3
ENST00000379127.1 ENST00000379133.3 |
C9orf24
|
chromosome 9 open reading frame 24 |
chr17_-_19290483 | 3.75 |
ENST00000395592.2
ENST00000299610.4 |
MFAP4
|
microfibrillar-associated protein 4 |
chr11_-_111781554 | 3.74 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
chr7_-_45128472 | 3.73 |
ENST00000490531.2
|
NACAD
|
NAC alpha domain containing |
chr5_+_71014990 | 3.72 |
ENST00000296777.4
|
CARTPT
|
CART prepropeptide |
chr1_+_47264711 | 3.70 |
ENST00000371923.4
ENST00000271153.4 ENST00000371919.4 |
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1 |
chr8_-_133493200 | 3.69 |
ENST00000388996.4
|
KCNQ3
|
potassium voltage-gated channel, KQT-like subfamily, member 3 |
chr12_-_50297638 | 3.69 |
ENST00000320634.3
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
chrX_+_53449887 | 3.67 |
ENST00000375327.3
|
RIBC1
|
RIB43A domain with coiled-coils 1 |
chr20_-_52612705 | 3.65 |
ENST00000434986.2
|
BCAS1
|
breast carcinoma amplified sequence 1 |
chr6_+_30851840 | 3.64 |
ENST00000511510.1
ENST00000376569.3 ENST00000376575.3 ENST00000376570.4 ENST00000446312.1 ENST00000504927.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chrX_+_53449805 | 3.63 |
ENST00000414955.2
|
RIBC1
|
RIB43A domain with coiled-coils 1 |
chr1_+_160085501 | 3.62 |
ENST00000361216.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr5_-_176057365 | 3.62 |
ENST00000310112.3
|
SNCB
|
synuclein, beta |
chr18_-_24765248 | 3.61 |
ENST00000580774.1
ENST00000284224.8 |
CHST9
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 |
chr11_-_130298888 | 3.60 |
ENST00000257359.6
|
ADAMTS8
|
ADAM metallopeptidase with thrombospondin type 1 motif, 8 |
chr19_-_47975417 | 3.60 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr17_-_41977964 | 3.59 |
ENST00000377184.3
|
MPP2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr12_+_57943781 | 3.58 |
ENST00000455537.2
ENST00000286452.5 |
KIF5A
|
kinesin family member 5A |
chr17_+_42385927 | 3.57 |
ENST00000426726.3
ENST00000590941.1 ENST00000225441.7 |
RUNDC3A
|
RUN domain containing 3A |
chr3_-_58643483 | 3.57 |
ENST00000483787.1
|
FAM3D
|
family with sequence similarity 3, member D |
chr16_+_55512742 | 3.56 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr5_+_175298487 | 3.56 |
ENST00000393745.3
|
CPLX2
|
complexin 2 |
chr20_-_55841662 | 3.55 |
ENST00000395863.3
ENST00000450594.2 |
BMP7
|
bone morphogenetic protein 7 |
chr1_+_77333117 | 3.54 |
ENST00000477717.1
|
ST6GALNAC5
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
chr19_+_35606777 | 3.54 |
ENST00000604404.1
ENST00000435734.2 ENST00000603181.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr1_-_153538292 | 3.53 |
ENST00000497140.1
ENST00000368708.3 |
S100A2
|
S100 calcium binding protein A2 |
chr4_-_90758118 | 3.53 |
ENST00000420646.2
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr1_+_160085567 | 3.52 |
ENST00000392233.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr20_+_53092232 | 3.52 |
ENST00000395939.1
|
DOK5
|
docking protein 5 |
chr18_-_24443151 | 3.52 |
ENST00000440832.3
|
AQP4
|
aquaporin 4 |
chr8_-_144241432 | 3.51 |
ENST00000430474.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr17_-_39677971 | 3.49 |
ENST00000393976.2
|
KRT15
|
keratin 15 |
chr6_-_112575912 | 3.47 |
ENST00000522006.1
ENST00000230538.7 ENST00000519932.1 |
LAMA4
|
laminin, alpha 4 |
chr6_+_123100620 | 3.45 |
ENST00000368444.3
|
FABP7
|
fatty acid binding protein 7, brain |
chr15_+_74466012 | 3.45 |
ENST00000249842.3
|
ISLR
|
immunoglobulin superfamily containing leucine-rich repeat |
chr4_-_168155577 | 3.44 |
ENST00000541354.1
ENST00000509854.1 ENST00000512681.1 ENST00000421836.2 ENST00000510741.1 ENST00000510403.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr1_+_111888890 | 3.44 |
ENST00000369738.4
|
PIFO
|
primary cilia formation |
chr21_+_27011584 | 3.44 |
ENST00000400532.1
ENST00000480456.1 ENST00000312957.5 |
JAM2
|
junctional adhesion molecule 2 |
chr15_+_43886057 | 3.42 |
ENST00000441322.1
ENST00000413657.2 ENST00000453733.1 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chrX_+_102585124 | 3.42 |
ENST00000332431.4
ENST00000372666.1 |
TCEAL7
|
transcription elongation factor A (SII)-like 7 |
chr3_+_111717600 | 3.42 |
ENST00000273368.4
|
TAGLN3
|
transgelin 3 |
chr7_-_140341251 | 3.41 |
ENST00000491728.1
|
DENND2A
|
DENN/MADD domain containing 2A |
chr11_-_5255696 | 3.40 |
ENST00000292901.3
ENST00000417377.1 |
HBD
|
hemoglobin, delta |
chrX_-_128788914 | 3.40 |
ENST00000429967.1
ENST00000307484.6 |
APLN
|
apelin |
chr16_+_29823427 | 3.40 |
ENST00000358758.7
ENST00000567659.1 ENST00000572820.1 |
PRRT2
|
proline-rich transmembrane protein 2 |
chr6_-_29600832 | 3.39 |
ENST00000377016.4
ENST00000376977.3 ENST00000377034.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr19_-_51472031 | 3.38 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr19_-_47975143 | 3.38 |
ENST00000597014.1
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr11_-_35547151 | 3.37 |
ENST00000378878.3
ENST00000529303.1 ENST00000278360.3 |
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
chr19_-_54984354 | 3.37 |
ENST00000301200.2
|
CDC42EP5
|
CDC42 effector protein (Rho GTPase binding) 5 |
chr11_+_118477144 | 3.37 |
ENST00000361417.2
|
PHLDB1
|
pleckstrin homology-like domain, family B, member 1 |
chr6_+_44238203 | 3.36 |
ENST00000451188.2
|
TMEM151B
|
transmembrane protein 151B |
chr14_-_23834411 | 3.36 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
chr19_-_36523529 | 3.35 |
ENST00000593074.1
|
CLIP3
|
CAP-GLY domain containing linker protein 3 |
chr4_-_168155700 | 3.34 |
ENST00000357545.4
ENST00000512648.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
chr17_-_42988004 | 3.34 |
ENST00000586125.1
ENST00000591880.1 |
GFAP
|
glial fibrillary acidic protein |
chr9_+_130374537 | 3.33 |
ENST00000373302.3
ENST00000373299.1 |
STXBP1
|
syntaxin binding protein 1 |
chr19_+_18718214 | 3.32 |
ENST00000600490.1
|
TMEM59L
|
transmembrane protein 59-like |
chr3_-_19975665 | 3.32 |
ENST00000295824.9
ENST00000389256.4 |
EFHB
|
EF-hand domain family, member B |
chr5_-_142000883 | 3.31 |
ENST00000359370.6
|
FGF1
|
fibroblast growth factor 1 (acidic) |
chr7_+_24324726 | 3.31 |
ENST00000405982.1
|
NPY
|
neuropeptide Y |
chr4_-_154710210 | 3.30 |
ENST00000274063.4
|
SFRP2
|
secreted frizzled-related protein 2 |
chr2_+_39893043 | 3.30 |
ENST00000281961.2
|
TMEM178A
|
transmembrane protein 178A |
chr19_+_19322758 | 3.29 |
ENST00000252575.6
|
NCAN
|
neurocan |
chr5_-_35938674 | 3.29 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
chr1_+_43613612 | 3.28 |
ENST00000335282.4
|
FAM183A
|
family with sequence similarity 183, member A |
chr11_-_12030681 | 3.27 |
ENST00000529338.1
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chr17_+_32582293 | 3.26 |
ENST00000580907.1
ENST00000225831.4 |
CCL2
|
chemokine (C-C motif) ligand 2 |
chr11_-_111781454 | 3.25 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
chrX_+_100474763 | 3.24 |
ENST00000395209.3
|
DRP2
|
dystrophin related protein 2 |
chr2_-_241737128 | 3.24 |
ENST00000404283.3
|
KIF1A
|
kinesin family member 1A |
chr19_-_291365 | 3.24 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
chr15_-_71146480 | 3.23 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
chr16_+_29911666 | 3.21 |
ENST00000563177.1
ENST00000483405.1 |
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
chr19_+_55795493 | 3.20 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
chr15_+_43985725 | 3.18 |
ENST00000413453.2
|
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr1_-_153588334 | 3.18 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
chr3_-_117716418 | 3.17 |
ENST00000484092.1
|
RP11-384F7.2
|
RP11-384F7.2 |
chr11_+_117947782 | 3.16 |
ENST00000522307.1
ENST00000523251.1 ENST00000437212.3 ENST00000522824.1 ENST00000522151.1 |
TMPRSS4
|
transmembrane protease, serine 4 |
chr16_+_56623433 | 3.15 |
ENST00000570176.1
|
MT3
|
metallothionein 3 |
chr2_+_220306745 | 3.15 |
ENST00000431523.1
ENST00000396698.1 ENST00000396695.2 |
SPEG
|
SPEG complex locus |
chr16_+_226658 | 3.15 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr9_-_34381511 | 3.14 |
ENST00000379124.1
|
C9orf24
|
chromosome 9 open reading frame 24 |
chr12_-_50294033 | 3.14 |
ENST00000552669.1
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
chr5_-_172755056 | 3.14 |
ENST00000520648.1
|
STC2
|
stanniocalcin 2 |
chr3_+_173115520 | 3.13 |
ENST00000413821.1
|
NLGN1
|
neuroligin 1 |
chr15_-_76005170 | 3.12 |
ENST00000308508.5
|
CSPG4
|
chondroitin sulfate proteoglycan 4 |
chrX_+_100474906 | 3.12 |
ENST00000541709.1
|
DRP2
|
dystrophin related protein 2 |
chr17_+_37783197 | 3.11 |
ENST00000582680.1
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr4_-_46392290 | 3.10 |
ENST00000515082.1
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
chr7_+_89841144 | 3.10 |
ENST00000394622.2
ENST00000394632.1 ENST00000426158.1 ENST00000394621.2 ENST00000402625.2 |
STEAP2
|
STEAP family member 2, metalloreductase |
chr2_+_17721937 | 3.09 |
ENST00000451533.1
|
VSNL1
|
visinin-like 1 |
chr6_+_30852738 | 3.09 |
ENST00000508312.1
ENST00000512336.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr1_-_95007193 | 3.07 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
chr17_+_37782955 | 3.05 |
ENST00000580825.1
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr10_-_10836919 | 3.05 |
ENST00000602763.1
ENST00000415590.2 ENST00000434919.2 |
SFTA1P
|
surfactant associated 1, pseudogene |
chrX_-_55057403 | 3.05 |
ENST00000396198.3
ENST00000335854.4 ENST00000455688.1 ENST00000330807.5 |
ALAS2
|
aminolevulinate, delta-, synthase 2 |
chr17_-_15165854 | 3.05 |
ENST00000395936.1
ENST00000395938.2 |
PMP22
|
peripheral myelin protein 22 |
chr15_+_43885252 | 3.04 |
ENST00000453782.1
ENST00000300283.6 ENST00000437924.1 ENST00000450086.2 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr17_-_42991062 | 3.04 |
ENST00000587997.1
|
GFAP
|
glial fibrillary acidic protein |
chr14_+_79745746 | 3.03 |
ENST00000281127.7
|
NRXN3
|
neurexin 3 |
chr5_-_176056974 | 3.03 |
ENST00000510387.1
ENST00000506696.1 |
SNCB
|
synuclein, beta |
chr5_+_175298573 | 3.02 |
ENST00000512824.1
|
CPLX2
|
complexin 2 |
chr6_-_112575687 | 3.02 |
ENST00000521398.1
ENST00000424408.2 ENST00000243219.3 |
LAMA4
|
laminin, alpha 4 |
chr2_+_219824357 | 3.02 |
ENST00000302625.4
|
CDK5R2
|
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
chr1_+_201592013 | 3.02 |
ENST00000593583.1
|
AC096677.1
|
Uncharacterized protein ENSP00000471857 |
chrX_-_128782722 | 3.01 |
ENST00000427399.1
|
APLN
|
apelin |
chr6_-_112575758 | 3.01 |
ENST00000431543.2
ENST00000453937.2 ENST00000368638.4 ENST00000389463.4 |
LAMA4
|
laminin, alpha 4 |
chr3_+_181429704 | 3.01 |
ENST00000431565.2
ENST00000325404.1 |
SOX2
|
SRY (sex determining region Y)-box 2 |
chr12_+_121078355 | 3.00 |
ENST00000316803.3
|
CABP1
|
calcium binding protein 1 |
chr16_+_77822427 | 3.00 |
ENST00000302536.2
|
VAT1L
|
vesicle amine transport 1-like |
chr6_-_31514516 | 2.99 |
ENST00000303892.5
ENST00000483251.1 |
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
chr19_-_47922373 | 2.99 |
ENST00000559524.1
ENST00000557833.1 ENST00000558555.1 ENST00000561293.1 ENST00000441740.2 |
MEIS3
|
Meis homeobox 3 |
chr3_-_73673991 | 2.98 |
ENST00000308537.4
ENST00000263666.4 |
PDZRN3
|
PDZ domain containing ring finger 3 |
chr17_+_37783453 | 2.97 |
ENST00000579000.1
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr5_-_41870621 | 2.97 |
ENST00000196371.5
|
OXCT1
|
3-oxoacid CoA transferase 1 |
chr4_-_46391931 | 2.97 |
ENST00000381620.4
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
chr14_+_23846328 | 2.95 |
ENST00000382809.2
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5 |
chr20_-_44168046 | 2.94 |
ENST00000372665.3
ENST00000372670.3 ENST00000600168.1 |
WFDC6
|
WAP four-disulfide core domain 6 |
chr3_-_58643458 | 2.94 |
ENST00000498347.1
|
FAM3D
|
family with sequence similarity 3, member D |
chr19_+_35606692 | 2.94 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chrX_+_103031421 | 2.94 |
ENST00000433491.1
ENST00000418604.1 ENST00000443502.1 |
PLP1
|
proteolipid protein 1 |
chrX_+_53449839 | 2.93 |
ENST00000457095.1
|
RIBC1
|
RIB43A domain with coiled-coils 1 |
chr19_+_51358166 | 2.92 |
ENST00000601503.1
ENST00000326003.2 ENST00000597286.1 ENST00000597483.1 |
KLK3
|
kallikrein-related peptidase 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.5 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
2.7 | 29.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.5 | 2.5 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
2.4 | 14.4 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
2.4 | 2.4 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
2.3 | 7.0 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
2.2 | 2.2 | GO:0048565 | digestive tract development(GO:0048565) |
2.2 | 6.5 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
2.1 | 8.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.9 | 5.8 | GO:0007412 | axon target recognition(GO:0007412) |
1.9 | 18.8 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
1.9 | 3.7 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
1.9 | 5.6 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
1.8 | 14.6 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
1.8 | 7.3 | GO:1990502 | dense core granule maturation(GO:1990502) |
1.8 | 5.3 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.7 | 5.1 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
1.6 | 4.8 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
1.6 | 4.7 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
1.5 | 1.5 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.5 | 4.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
1.5 | 4.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.5 | 7.7 | GO:0035962 | response to interleukin-13(GO:0035962) |
1.5 | 7.5 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
1.5 | 4.5 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
1.5 | 5.9 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
1.5 | 10.3 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.5 | 4.4 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
1.5 | 4.4 | GO:0048174 | negative regulation of short-term neuronal synaptic plasticity(GO:0048174) |
1.4 | 2.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.4 | 5.8 | GO:1905069 | allantois development(GO:1905069) |
1.4 | 1.4 | GO:0030030 | cell projection organization(GO:0030030) |
1.4 | 5.7 | GO:0030185 | nitric oxide transport(GO:0030185) |
1.4 | 5.6 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
1.4 | 4.2 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
1.4 | 6.9 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.4 | 34.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.4 | 1.4 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
1.3 | 6.6 | GO:0051866 | general adaptation syndrome(GO:0051866) |
1.3 | 4.0 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
1.3 | 3.9 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.3 | 5.2 | GO:0097115 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
1.3 | 8.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.3 | 1.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.2 | 1.2 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
1.2 | 3.7 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
1.2 | 3.7 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
1.2 | 2.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
1.2 | 6.0 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
1.2 | 3.5 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
1.2 | 5.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.1 | 3.4 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
1.1 | 3.4 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.1 | 26.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.1 | 3.3 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
1.1 | 4.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.1 | 12.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.1 | 1.1 | GO:0060166 | olfactory pit development(GO:0060166) |
1.1 | 4.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
1.1 | 3.3 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
1.1 | 5.4 | GO:0021586 | pons maturation(GO:0021586) |
1.1 | 3.3 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
1.1 | 1.1 | GO:1902749 | regulation of cell cycle G2/M phase transition(GO:1902749) |
1.1 | 21.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.1 | 9.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.1 | 3.2 | GO:0003294 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
1.1 | 3.2 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
1.1 | 4.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
1.0 | 1.0 | GO:0072098 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
1.0 | 3.1 | GO:0040040 | thermosensory behavior(GO:0040040) |
1.0 | 4.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
1.0 | 3.1 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.0 | 13.1 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
1.0 | 3.0 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
1.0 | 2.0 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
1.0 | 14.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.0 | 25.9 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
1.0 | 4.9 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
1.0 | 1.0 | GO:0060435 | bronchiole development(GO:0060435) |
1.0 | 3.9 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
1.0 | 1.0 | GO:0010171 | body morphogenesis(GO:0010171) |
1.0 | 3.9 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
1.0 | 10.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.0 | 3.9 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
1.0 | 1.0 | GO:0007521 | muscle cell fate determination(GO:0007521) |
1.0 | 2.9 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
1.0 | 2.9 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
1.0 | 2.9 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.9 | 3.8 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.9 | 4.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.9 | 2.8 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.9 | 9.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.9 | 3.7 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
0.9 | 47.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.9 | 2.8 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) |
0.9 | 10.3 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.9 | 13.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.9 | 3.7 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.9 | 0.9 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
0.9 | 5.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.9 | 2.7 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.9 | 2.7 | GO:1904596 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.9 | 19.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.9 | 2.7 | GO:0086070 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.9 | 13.6 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.9 | 7.3 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.9 | 12.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.9 | 2.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.9 | 3.6 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
0.9 | 2.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.9 | 4.4 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.9 | 5.3 | GO:0042335 | cuticle development(GO:0042335) |
0.9 | 2.7 | GO:0048925 | lateral line system development(GO:0048925) |
0.9 | 2.6 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.9 | 18.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.9 | 4.3 | GO:0048749 | compound eye development(GO:0048749) |
0.9 | 2.6 | GO:0021893 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.9 | 1.7 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.9 | 0.9 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.9 | 5.1 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
0.8 | 3.4 | GO:0060254 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
0.8 | 7.6 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.8 | 0.8 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.8 | 0.8 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.8 | 10.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.8 | 4.2 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.8 | 0.8 | GO:0070666 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.8 | 23.9 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.8 | 6.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.8 | 3.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.8 | 0.8 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.8 | 4.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.8 | 4.1 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.8 | 1.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.8 | 6.4 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.8 | 3.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.8 | 9.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.8 | 7.9 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.8 | 2.4 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.8 | 4.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.8 | 3.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.8 | 2.4 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.8 | 5.5 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.8 | 18.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.8 | 4.7 | GO:0030421 | defecation(GO:0030421) |
0.8 | 5.5 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.8 | 0.8 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.8 | 3.9 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.8 | 1.6 | GO:0090427 | activation of meiosis(GO:0090427) |
0.8 | 4.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.8 | 16.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.8 | 0.8 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.8 | 3.1 | GO:0032773 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.8 | 0.8 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
0.8 | 0.8 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.8 | 1.5 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.8 | 3.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.8 | 7.6 | GO:0097646 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.8 | 3.0 | GO:0050975 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
0.8 | 0.8 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
0.8 | 6.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.8 | 2.3 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.8 | 6.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.8 | 2.3 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
0.8 | 3.0 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.8 | 0.8 | GO:0060594 | mammary gland specification(GO:0060594) |
0.7 | 1.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.7 | 0.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.7 | 0.7 | GO:0044335 | canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
0.7 | 3.0 | GO:0018277 | protein deamination(GO:0018277) |
0.7 | 3.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.7 | 0.7 | GO:1902680 | positive regulation of RNA biosynthetic process(GO:1902680) |
0.7 | 0.7 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.7 | 0.7 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.7 | 3.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.7 | 4.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.7 | 0.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.7 | 5.7 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.7 | 2.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.7 | 4.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.7 | 4.3 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.7 | 2.1 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.7 | 2.1 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.7 | 7.8 | GO:0035766 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.7 | 2.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.7 | 2.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.7 | 4.9 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.7 | 3.5 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.7 | 2.1 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.7 | 2.1 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.7 | 4.1 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.7 | 0.7 | GO:0070662 | mast cell proliferation(GO:0070662) |
0.7 | 6.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.7 | 2.8 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.7 | 4.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.7 | 15.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.7 | 2.0 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.7 | 0.7 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.7 | 12.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.7 | 0.7 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
0.7 | 3.4 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.7 | 2.0 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.7 | 3.3 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.7 | 2.7 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.7 | 2.7 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.7 | 1.3 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.7 | 4.0 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.7 | 10.6 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.7 | 0.7 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.7 | 2.0 | GO:0018969 | thiocyanate metabolic process(GO:0018969) |
0.7 | 13.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.7 | 6.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.6 | 1.3 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.6 | 1.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.6 | 1.9 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
0.6 | 11.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.6 | 0.6 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.6 | 1.9 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.6 | 0.6 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.6 | 2.6 | GO:0072143 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.6 | 1.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.6 | 13.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 1.9 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.6 | 0.6 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.6 | 1.3 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.6 | 1.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.6 | 5.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.6 | 3.2 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.6 | 2.5 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.6 | 1.9 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.6 | 1.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.6 | 1.9 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.6 | 1.9 | GO:0050894 | determination of affect(GO:0050894) |
0.6 | 1.9 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.6 | 5.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 3.1 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.6 | 9.9 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.6 | 1.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.6 | 2.5 | GO:0036269 | swimming behavior(GO:0036269) |
0.6 | 3.6 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.6 | 4.2 | GO:0021759 | globus pallidus development(GO:0021759) |
0.6 | 3.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 1.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.6 | 2.4 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.6 | 0.6 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.6 | 1.8 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.6 | 2.4 | GO:0071503 | response to heparin(GO:0071503) |
0.6 | 1.2 | GO:0072254 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
0.6 | 5.9 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.6 | 2.9 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
0.6 | 1.2 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.6 | 13.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.6 | 21.9 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.6 | 3.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.6 | 4.0 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.6 | 0.6 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.6 | 9.6 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.6 | 1.1 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.6 | 0.6 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.6 | 1.7 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
0.6 | 1.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.6 | 0.6 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.6 | 10.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.6 | 2.2 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.6 | 0.6 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.6 | 1.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.6 | 1.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.5 | 2.2 | GO:0009956 | radial pattern formation(GO:0009956) |
0.5 | 3.3 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.5 | 2.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.5 | 2.2 | GO:0072302 | posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.5 | 4.3 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.5 | 7.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.5 | 13.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 1.6 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.5 | 2.1 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.5 | 1.6 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.5 | 2.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.5 | 2.7 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 1.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.5 | 9.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.5 | 1.6 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.5 | 2.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.5 | 4.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.5 | 2.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.5 | 2.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 1.6 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.5 | 4.6 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.5 | 2.1 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.5 | 0.5 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.5 | 1.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.5 | 3.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 8.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 19.9 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.5 | 2.5 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.5 | 2.0 | GO:1900191 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.5 | 1.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 16.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.5 | 5.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.5 | 2.0 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.5 | 1.5 | GO:0090265 | positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
0.5 | 2.0 | GO:0045575 | basophil activation(GO:0045575) |
0.5 | 1.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.5 | 3.5 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 2.0 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.5 | 0.5 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
0.5 | 4.9 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.5 | 4.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 1.5 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.5 | 2.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 2.4 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.5 | 2.4 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.5 | 2.9 | GO:0018032 | protein amidation(GO:0018032) |
0.5 | 0.5 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.5 | 1.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.5 | 0.5 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.5 | 6.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 1.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 1.4 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.5 | 1.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.5 | 1.4 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.5 | 1.0 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.5 | 2.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.5 | 1.4 | GO:0061571 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
0.5 | 2.9 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.5 | 1.9 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.5 | 1.9 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.5 | 6.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 1.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.5 | 9.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.5 | 5.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 1.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.5 | 5.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.5 | 0.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.5 | 0.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.5 | 10.8 | GO:0035640 | exploration behavior(GO:0035640) |
0.5 | 1.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 1.4 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.5 | 2.3 | GO:1904141 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.5 | 3.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.5 | 21.7 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.5 | 1.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 7.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 3.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.5 | 1.8 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.5 | 0.9 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.5 | 3.6 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.5 | 0.9 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 3.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.4 | 0.4 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.4 | 2.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 1.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.4 | 3.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 0.9 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.4 | 2.6 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 0.9 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.4 | 0.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.4 | 8.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.4 | 1.3 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.4 | 2.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 1.7 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.4 | 2.1 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.4 | 0.8 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.4 | 1.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.4 | 0.4 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
0.4 | 1.7 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.4 | 3.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 5.0 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.4 | 0.8 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.4 | 2.5 | GO:1990834 | response to odorant(GO:1990834) |
0.4 | 5.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 2.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.4 | 5.4 | GO:0035878 | nail development(GO:0035878) |
0.4 | 4.1 | GO:0010810 | regulation of cell-substrate adhesion(GO:0010810) |
0.4 | 2.9 | GO:0001878 | response to yeast(GO:0001878) |
0.4 | 3.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 3.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.4 | 2.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 0.4 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.4 | 13.5 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.4 | 1.6 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.4 | 0.4 | GO:0007492 | endoderm development(GO:0007492) |
0.4 | 1.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 2.0 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.4 | 3.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.4 | 1.2 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.4 | 4.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 2.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.4 | 0.8 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.4 | 0.8 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) positive regulation of macrophage differentiation(GO:0045651) |
0.4 | 0.4 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.4 | 8.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 3.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 2.0 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.4 | 2.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 1.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.4 | 1.6 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.4 | 2.0 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.4 | 6.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.4 | 30.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 0.4 | GO:0070305 | response to cGMP(GO:0070305) |
0.4 | 2.3 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.4 | 27.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 10.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.4 | 2.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 3.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 0.8 | GO:0090330 | regulation of platelet aggregation(GO:0090330) |
0.4 | 1.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 0.8 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.4 | 1.9 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.4 | 1.1 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.4 | 3.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.4 | 1.9 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.4 | 0.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 1.9 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.4 | 6.1 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.4 | 1.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 5.7 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.4 | 1.5 | GO:0002118 | aggressive behavior(GO:0002118) |
0.4 | 13.1 | GO:0033622 | integrin activation(GO:0033622) |
0.4 | 3.0 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.4 | 10.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.4 | 1.5 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.4 | 3.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 6.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 2.2 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.4 | 0.7 | GO:0043305 | negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
0.4 | 8.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 14.8 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.4 | 2.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 3.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.4 | 5.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.4 | 3.3 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.4 | 1.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.4 | 0.4 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.4 | 1.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.4 | 1.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 3.6 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.4 | 1.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 6.5 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.4 | 10.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 0.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 1.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 1.8 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.4 | 1.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 2.5 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.4 | 1.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.4 | 0.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.4 | 0.7 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 1.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.3 | 0.7 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.3 | 1.4 | GO:2000173 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.3 | 3.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 4.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 2.8 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.3 | 1.0 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.3 | 0.7 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.3 | 2.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 7.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.4 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.3 | 1.0 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.3 | 0.3 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.3 | 1.0 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.3 | 6.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.3 | 1.0 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.3 | 0.3 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 0.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.3 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 0.7 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.3 | 0.7 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.3 | 9.3 | GO:0097484 | dendrite extension(GO:0097484) |
0.3 | 2.7 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.3 | 1.0 | GO:2001037 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.3 | 0.7 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.3 | 3.6 | GO:0008038 | neuron recognition(GO:0008038) |
0.3 | 1.0 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.3 | 4.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 1.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 1.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 1.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.3 | 1.3 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.3 | 2.6 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) lung ciliated cell differentiation(GO:0061141) |
0.3 | 1.6 | GO:1900193 | regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 0.3 | GO:0043200 | response to amino acid(GO:0043200) |
0.3 | 0.6 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.3 | 1.6 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.3 | 1.9 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.3 | 0.3 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 0.3 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.3 | 1.9 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.3 | 0.6 | GO:0021782 | glial cell development(GO:0021782) |
0.3 | 2.5 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.3 | 2.5 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 1.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.3 | 1.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 1.9 | GO:2000825 | regulation of androgen receptor activity(GO:2000823) positive regulation of androgen receptor activity(GO:2000825) |
0.3 | 1.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 0.9 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.3 | 1.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 2.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.3 | 0.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.9 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.3 | 1.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.3 | 1.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 11.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.2 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.3 | 8.2 | GO:0035082 | axoneme assembly(GO:0035082) |
0.3 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 1.2 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.3 | 0.9 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.3 | 0.6 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.3 | 1.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 4.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.3 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.3 | 1.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.3 | 2.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.3 | 1.2 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.3 | 5.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 1.8 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.3 | 1.2 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.3 | 1.5 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.3 | 7.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.3 | 0.6 | GO:0001825 | blastocyst formation(GO:0001825) |
0.3 | 0.6 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 0.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.3 | 1.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.3 | 3.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 11.1 | GO:0042551 | neuron maturation(GO:0042551) |
0.3 | 0.3 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.3 | 23.9 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.3 | 2.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 9.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.3 | 0.9 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.3 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.3 | 2.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 3.5 | GO:0015824 | proline transport(GO:0015824) |
0.3 | 2.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.3 | 0.3 | GO:0060592 | mammary gland formation(GO:0060592) |
0.3 | 2.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.3 | 7.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.3 | 1.4 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.3 | 0.3 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.3 | 2.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.3 | 1.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 1.4 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.3 | 2.3 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.3 | 2.8 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.3 | 2.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.3 | 1.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 0.3 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.3 | 2.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.3 | 0.8 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 1.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 0.6 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 0.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.3 | 1.1 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.3 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.3 | 3.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.3 | 2.7 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 0.8 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.3 | 1.1 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.3 | 0.8 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 0.5 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.3 | 1.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 0.5 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.3 | 0.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 0.5 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.3 | 3.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 0.5 | GO:0046666 | retinal cell programmed cell death(GO:0046666) positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.3 | 1.1 | GO:0060322 | head development(GO:0060322) |
0.3 | 1.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 2.1 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.3 | 1.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 2.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.3 | 0.3 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
0.3 | 0.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 0.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.3 | 4.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.3 | 9.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 2.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 0.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 0.8 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
0.3 | 2.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 0.8 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
0.3 | 0.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 11.6 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.3 | 6.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.2 | 1.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 1.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 1.5 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.2 | 3.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 0.7 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.2 | 1.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 4.9 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 1.2 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.2 | 0.7 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.2 | 2.2 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.2 | 0.7 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.2 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.5 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.2 | 0.5 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.2 | 0.5 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 2.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 1.2 | GO:0051592 | response to calcium ion(GO:0051592) |
0.2 | 1.0 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.2 | 1.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.2 | 1.2 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.2 | 1.2 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 0.9 | GO:0072378 | blood coagulation, intrinsic pathway(GO:0007597) blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 3.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.2 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 2.4 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.2 | 0.5 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.2 | 0.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 1.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.9 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.2 | 0.2 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.2 | 0.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 2.8 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.2 | 0.2 | GO:0060577 | pulmonary vein morphogenesis(GO:0060577) |
0.2 | 2.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 1.6 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.2 | 2.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 2.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 2.5 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.2 | 0.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 1.2 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.2 | 0.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 1.1 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.2 | 2.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.2 | 3.0 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.2 | 0.7 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
0.2 | 0.5 | GO:0061136 | regulation of proteasomal protein catabolic process(GO:0061136) |
0.2 | 1.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.2 | 0.9 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 1.1 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.2 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.4 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
0.2 | 0.7 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 3.1 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.2 | 1.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 26.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 4.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 0.9 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.2 | 2.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 0.2 | GO:0000019 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
0.2 | 0.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 1.8 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 1.1 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.2 | 2.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 2.0 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.2 | 2.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.7 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
0.2 | 0.2 | GO:0051414 | response to cortisol(GO:0051414) |
0.2 | 1.8 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.2 | 3.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 4.6 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.2 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 1.5 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.2 | 2.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.2 | 0.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 0.9 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.2 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 0.6 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
0.2 | 1.5 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.2 | 2.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 1.3 | GO:0007320 | insemination(GO:0007320) |
0.2 | 0.6 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 1.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 1.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 2.5 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 5.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 0.4 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.2 | 0.4 | GO:1904377 | positive regulation of protein localization to cell periphery(GO:1904377) |
0.2 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.6 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 2.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 0.8 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.2 | 36.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 1.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.2 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.2 | 0.4 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.2 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
0.2 | 2.8 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.4 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 4.8 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.2 | 1.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.4 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.2 | 2.2 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 1.0 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 3.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 2.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.2 | 14.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 0.8 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.2 | 2.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 4.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 1.6 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.2 | 0.8 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.2 | 1.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 0.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 1.0 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.2 | 1.0 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 0.4 | GO:0033555 | multicellular organismal response to stress(GO:0033555) |
0.2 | 2.7 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.2 | 7.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 4.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 6.8 | GO:0003341 | cilium movement(GO:0003341) |
0.2 | 1.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 4.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.2 | 0.4 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 2.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 1.5 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.2 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
0.2 | 0.7 | GO:0003335 | corneocyte development(GO:0003335) |
0.2 | 0.2 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.2 | 0.4 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 0.7 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
0.2 | 0.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.9 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.2 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.2 | GO:0072312 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.2 | 1.8 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.2 | 19.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 6.9 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.2 | 0.9 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 0.5 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.2 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.2 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.2 | 5.3 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 0.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 1.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.4 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.5 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 1.0 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.2 | 0.5 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.2 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.2 | 0.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.2 | 0.2 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.2 | 0.2 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.2 | 3.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.2 | 0.2 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.2 | 0.8 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.2 | 2.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.2 | 0.8 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.2 | 0.2 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
0.2 | 1.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 2.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 2.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 0.5 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.2 | 0.3 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.2 | 0.7 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.2 | 1.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 2.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.2 | 1.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 2.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.3 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 1.0 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
0.2 | 1.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.2 | 1.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.5 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.2 | 1.0 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.2 | 1.1 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.2 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.8 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.2 | 1.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 0.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.2 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 0.8 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.2 | 0.8 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.2 | 0.6 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.2 | 4.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 2.1 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.2 | 5.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.8 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 0.8 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.2 | 0.3 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 0.9 | GO:0007625 | grooming behavior(GO:0007625) |
0.2 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.5 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.2 | 1.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 3.6 | GO:0006825 | copper ion transport(GO:0006825) |
0.2 | 0.5 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.2 | 2.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.6 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 1.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.2 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.2 | 0.8 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.2 | 1.8 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.5 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.2 | 0.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 1.1 | GO:2000018 | regulation of male gonad development(GO:2000018) positive regulation of male gonad development(GO:2000020) |
0.1 | 0.7 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 5.5 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.4 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.1 | 2.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.6 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 1.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.6 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 2.0 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 1.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 1.9 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.6 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.1 | 0.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.1 | 12.0 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.1 | 2.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 4.6 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.1 | 0.4 | GO:0090260 | negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.1 | 1.1 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 3.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 5.2 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 3.1 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 17.2 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 4.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.4 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 1.8 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.8 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 1.0 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.1 | 0.6 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 2.3 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.4 | GO:0098773 | skin epidermis development(GO:0098773) |
0.1 | 6.8 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.8 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 1.7 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.4 | GO:0014033 | neural crest cell differentiation(GO:0014033) |
0.1 | 0.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.3 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.9 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 1.5 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.4 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.1 | 0.3 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.1 | 1.7 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 4.0 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 2.8 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 2.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.5 | GO:1903979 | negative regulation of microglial cell activation(GO:1903979) |
0.1 | 0.5 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.1 | 0.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.2 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.1 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.7 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 0.9 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 1.2 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 2.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 1.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.5 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 1.0 | GO:0046323 | glucose import(GO:0046323) |
0.1 | 0.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.1 | GO:0032213 | regulation of telomere maintenance via semi-conservative replication(GO:0032213) negative regulation of telomere maintenance via semi-conservative replication(GO:0032214) |
0.1 | 0.6 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 1.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 1.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 1.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.4 | GO:0014812 | muscle cell migration(GO:0014812) |
0.1 | 1.3 | GO:0030031 | cell projection assembly(GO:0030031) |
0.1 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 4.1 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 2.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 6.8 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.5 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.3 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 0.3 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.1 | 0.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 1.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.2 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 8.4 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.1 | 2.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.7 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 0.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 1.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.3 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 0.6 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.2 | GO:0045606 | epidermal cell fate specification(GO:0009957) positive regulation of epidermal cell differentiation(GO:0045606) |
0.1 | 0.4 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.1 | 0.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.3 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 0.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 1.4 | GO:0071383 | cellular response to steroid hormone stimulus(GO:0071383) |
0.1 | 0.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 1.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.6 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 1.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.9 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.1 | 0.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.5 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 1.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.3 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 1.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 3.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.7 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 2.8 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.5 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.6 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 0.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 3.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.1 | 0.6 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.4 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.4 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.3 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.1 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.5 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 1.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.7 | GO:0060996 | dendritic spine development(GO:0060996) |
0.1 | 0.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.4 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.1 | 0.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.5 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.5 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.1 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.2 | GO:1903410 | nitric oxide production involved in inflammatory response(GO:0002537) lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.1 | 0.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.2 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
0.1 | 0.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 1.2 | GO:0009799 | specification of symmetry(GO:0009799) |
0.1 | 0.4 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.1 | 3.6 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 3.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 1.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.1 | GO:0039020 | pronephric nephron tubule development(GO:0039020) |
0.1 | 1.1 | GO:0014854 | response to inactivity(GO:0014854) |
0.1 | 1.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.3 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.8 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
0.1 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.5 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.5 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) positive regulation of metalloendopeptidase activity(GO:1904685) |
0.1 | 0.3 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.1 | 0.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.1 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 | 0.9 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.4 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
0.1 | 0.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.6 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.4 | GO:0048511 | rhythmic process(GO:0048511) |
0.1 | 0.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.3 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 1.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.8 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 0.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.1 | 0.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.2 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.1 | 1.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.7 | GO:0007164 | establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
0.1 | 1.2 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 6.1 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 0.2 | GO:0086009 | membrane repolarization(GO:0086009) |
0.1 | 0.7 | GO:0061072 | pancreatic A cell development(GO:0003322) iris morphogenesis(GO:0061072) |
0.1 | 0.6 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 3.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
0.1 | 0.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.1 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.4 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.1 | 1.0 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
0.1 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 2.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.2 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.2 | GO:1901983 | regulation of histone acetylation(GO:0035065) regulation of protein acetylation(GO:1901983) |
0.1 | 0.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 2.3 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.1 | GO:0090342 | regulation of cell aging(GO:0090342) |
0.1 | 1.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 7.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 2.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.1 | GO:1901258 | sensory system development(GO:0048880) cardiac cell fate determination(GO:0060913) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 1.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.3 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.7 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 2.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.4 | GO:0048858 | cell projection morphogenesis(GO:0048858) |
0.1 | 0.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 6.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.4 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 5.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.3 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 3.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 0.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.8 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 1.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 2.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.7 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 3.0 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.4 | GO:1990539 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.1 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.8 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.1 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.1 | 0.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0033590 | response to cobalamin(GO:0033590) |
0.1 | 0.1 | GO:0034699 | response to luteinizing hormone(GO:0034699) |
0.1 | 0.1 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.2 | GO:0060872 | semicircular canal development(GO:0060872) |
0.1 | 0.6 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.1 | 1.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 3.0 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.7 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0007507 | heart development(GO:0007507) |
0.1 | 1.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.5 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.6 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
0.1 | 0.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.1 | 0.2 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.1 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.2 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.1 | 0.2 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.7 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 0.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.1 | 1.2 | GO:0048512 | circadian behavior(GO:0048512) |
0.1 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 5.3 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.1 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.1 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
0.1 | 0.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.3 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 1.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 | 0.1 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.1 | 0.3 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.4 | GO:0070487 | monocyte aggregation(GO:0070487) |
0.1 | 1.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 1.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.2 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 1.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.4 | GO:0006875 | cellular metal ion homeostasis(GO:0006875) |
0.0 | 0.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 0.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 1.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.2 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.0 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.7 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 2.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.0 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.0 | 0.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.1 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.5 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.0 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.5 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
0.0 | 0.3 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.5 | GO:0007631 | feeding behavior(GO:0007631) |
0.0 | 2.0 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 1.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.0 | 0.7 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.0 | GO:0071046 | nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.6 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.8 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 0.2 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.0 | 0.4 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.0 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.0 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.0 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.0 | 0.1 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
0.0 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.0 | 0.2 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.4 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.0 | 0.1 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.0 | 0.1 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
0.0 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.0 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.2 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.1 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.0 | 0.4 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.0 | 0.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 1.9 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.5 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 1.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.0 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.0 | 0.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.0 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.2 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 0.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) |
0.0 | 0.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.0 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.0 | GO:0070507 | regulation of microtubule cytoskeleton organization(GO:0070507) |
0.0 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.2 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.0 | 0.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.0 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.0 | 0.1 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.0 | 0.3 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.0 | 0.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.0 | 0.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.6 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.0 | 0.1 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.0 | 0.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.3 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.0 | 0.1 | GO:0015811 | L-cystine transport(GO:0015811) |
0.0 | 0.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 0.4 | GO:0021915 | neural tube development(GO:0021915) |
0.0 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.3 | GO:0002009 | morphogenesis of an epithelium(GO:0002009) |
0.0 | 0.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 4.2 | GO:0098916 | chemical synaptic transmission(GO:0007268) anterograde trans-synaptic signaling(GO:0098916) |
0.0 | 0.0 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.0 | 0.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0071103 | DNA conformation change(GO:0071103) |
0.0 | 6.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.0 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.0 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.0 | 0.2 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 0.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.2 | GO:0042991 | transcription factor import into nucleus(GO:0042991) |
0.0 | 0.1 | GO:0001774 | microglial cell activation(GO:0001774) |
0.0 | 0.2 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) |
0.0 | 0.2 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.0 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.1 | GO:0051987 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
0.0 | 0.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0035900 | response to isolation stress(GO:0035900) |
0.0 | 0.1 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
0.0 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 1.7 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 1.3 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.0 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 1.2 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.5 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.0 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.0 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.1 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.0 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.0 | 0.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.0 | 0.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.4 | GO:0050808 | synapse organization(GO:0050808) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.3 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.0 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.0 | GO:1903169 | regulation of calcium ion transmembrane transport(GO:1903169) |
0.0 | 0.4 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.0 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.7 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.0 | GO:0035803 | egg coat formation(GO:0035803) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 9.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
2.2 | 13.0 | GO:0044308 | axonal spine(GO:0044308) |
2.1 | 38.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.0 | 7.9 | GO:0072534 | perineuronal net(GO:0072534) |
1.9 | 1.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.8 | 18.3 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
1.6 | 6.4 | GO:0030849 | autosome(GO:0030849) |
1.5 | 5.9 | GO:0060187 | cell pole(GO:0060187) |
1.3 | 3.9 | GO:0043257 | laminin-8 complex(GO:0043257) |
1.3 | 1.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.2 | 3.5 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
1.1 | 3.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.1 | 7.6 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
1.1 | 7.5 | GO:0032589 | neuron projection membrane(GO:0032589) |
1.1 | 3.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
1.0 | 11.5 | GO:0071953 | elastic fiber(GO:0071953) |
1.0 | 4.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
1.0 | 17.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.0 | 5.0 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
1.0 | 3.0 | GO:0044299 | C-fiber(GO:0044299) |
1.0 | 12.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.0 | 37.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.0 | 5.8 | GO:0032280 | symmetric synapse(GO:0032280) |
1.0 | 5.7 | GO:1990742 | microvesicle(GO:1990742) |
0.9 | 0.9 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.9 | 4.7 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.9 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.9 | 2.8 | GO:0097447 | dendritic tree(GO:0097447) |
0.9 | 3.7 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.9 | 4.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.9 | 2.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.9 | 14.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 17.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.9 | 5.3 | GO:0031673 | H zone(GO:0031673) |
0.9 | 1.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.9 | 2.6 | GO:0070702 | inner mucus layer(GO:0070702) outer mucus layer(GO:0070703) |
0.9 | 6.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.8 | 4.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.8 | 6.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.8 | 2.5 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.8 | 4.9 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.8 | 4.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.8 | 7.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.8 | 8.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 2.3 | GO:0001534 | radial spoke(GO:0001534) |
0.7 | 21.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 4.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.7 | 0.7 | GO:0044301 | climbing fiber(GO:0044301) |
0.7 | 3.0 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.7 | 7.2 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.7 | 2.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 9.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.7 | 2.0 | GO:0098855 | HCN channel complex(GO:0098855) |
0.7 | 19.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.6 | 3.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.6 | 14.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.6 | 1.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 1.9 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.6 | 2.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.6 | 3.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.6 | 1.2 | GO:0070701 | mucus layer(GO:0070701) |
0.6 | 3.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.6 | 2.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.6 | 9.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.6 | 25.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 5.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.6 | 6.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 4.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.6 | 2.3 | GO:0016013 | syntrophin complex(GO:0016013) |
0.6 | 4.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.6 | 1.1 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.6 | 1.7 | GO:0097444 | spine apparatus(GO:0097444) |
0.6 | 7.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.6 | 13.9 | GO:0005605 | basal lamina(GO:0005605) |
0.6 | 6.1 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.6 | 4.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.5 | 2.2 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.5 | 3.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 15.6 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 29.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 4.7 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.5 | 5.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.5 | 0.5 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.5 | 21.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.5 | 4.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 3.0 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 5.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.5 | 0.5 | GO:0036457 | keratohyalin granule(GO:0036457) |
0.5 | 7.9 | GO:0033268 | node of Ranvier(GO:0033268) |
0.5 | 2.9 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 1.5 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.5 | 2.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.5 | 1.9 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.5 | 10.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.5 | 7.2 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 1.4 | GO:0044305 | calyx of Held(GO:0044305) |
0.5 | 2.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 49.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 2.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 9.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 1.4 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.5 | 3.7 | GO:0060076 | excitatory synapse(GO:0060076) |
0.5 | 31.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 31.2 | GO:0030315 | T-tubule(GO:0030315) |
0.4 | 5.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 0.9 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.4 | 12.0 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 1.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 13.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 2.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 14.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 1.6 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.4 | 5.9 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 5.5 | GO:0043218 | compact myelin(GO:0043218) |
0.4 | 1.6 | GO:0031213 | RSF complex(GO:0031213) |
0.4 | 12.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 0.4 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.4 | 3.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 2.3 | GO:0032021 | NELF complex(GO:0032021) |
0.4 | 5.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 14.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.4 | 6.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 4.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.4 | 2.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.4 | 1.5 | GO:0033011 | perinuclear theca(GO:0033011) |
0.4 | 56.5 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 2.9 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 22.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.4 | 6.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.4 | 2.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.4 | 0.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 5.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 2.8 | GO:0002177 | manchette(GO:0002177) |
0.3 | 1.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.7 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.3 | 46.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.3 | 4.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 37.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 1.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 4.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 6.2 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 89.4 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.3 | 1.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.3 | 2.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 12.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 3.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 0.3 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.3 | 2.6 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.3 | 0.9 | GO:0044393 | microspike(GO:0044393) |
0.3 | 150.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.3 | 2.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 2.0 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.3 | 1.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.3 | 5.2 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 5.5 | GO:0097227 | sperm annulus(GO:0097227) |
0.3 | 1.4 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 46.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 0.8 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.3 | 2.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 1.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 1.0 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 2.8 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 1.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 21.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 1.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.7 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.2 | 1.7 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 5.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 24.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 8.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 3.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.9 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.2 | 6.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 1.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.4 | GO:0043291 | RAVE complex(GO:0043291) |
0.2 | 1.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 6.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 3.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 10.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 3.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.8 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.2 | 0.8 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.2 | 2.8 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.0 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 0.8 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.2 | 0.8 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.2 | 0.6 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.2 | 0.4 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 1.9 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 3.5 | GO:0043034 | costamere(GO:0043034) |
0.2 | 1.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 41.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 1.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 12.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 13.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 6.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.2 | 1.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.5 | GO:0035101 | FACT complex(GO:0035101) |
0.2 | 1.0 | GO:0032044 | DSIF complex(GO:0032044) |
0.2 | 57.0 | GO:0043025 | neuronal cell body(GO:0043025) |
0.2 | 11.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 0.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.2 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 1.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.7 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 10.2 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 0.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.2 | 7.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.5 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.2 | 0.5 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.2 | 2.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 3.2 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.9 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 1.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 1.0 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 2.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 8.5 | GO:0005901 | caveola(GO:0005901) |
0.1 | 21.2 | GO:0098793 | presynapse(GO:0098793) |
0.1 | 2.9 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 1.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 1.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 13.1 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.1 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
0.1 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 11.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 28.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 18.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 3.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.0 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 1.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.1 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.1 | 2.3 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 2.2 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.1 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 1.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 14.9 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 2.3 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.2 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 1.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 2.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 3.3 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 3.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 3.2 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 0.3 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.1 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.9 | GO:0000801 | central element(GO:0000801) |
0.1 | 10.1 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 10.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 6.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.5 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 11.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 21.1 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 1.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 3.3 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 5.1 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 1.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 3.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 2.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.2 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.1 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.2 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.1 | 0.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.1 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.2 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.1 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.3 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 3.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.1 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
0.1 | 0.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 0.1 | GO:0019034 | viral replication complex(GO:0019034) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 6.2 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 2.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.7 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 1.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 3.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 4.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 3.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 27.4 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 1.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 2.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.8 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.2 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.0 | 0.2 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.0 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 7.4 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.2 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.0 | 5.9 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 23.3 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.3 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.2 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.1 | GO:0070985 | TFIIK complex(GO:0070985) |
0.0 | 0.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 1.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0042025 | host cell nucleus(GO:0042025) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0033643 | host cell part(GO:0033643) |
0.0 | 0.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.0 | 0.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.6 | GO:0035861 | site of double-strand break(GO:0035861) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 15.1 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
2.4 | 12.2 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
2.3 | 11.7 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
2.1 | 10.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.9 | 18.8 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
1.8 | 5.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.8 | 3.6 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
1.6 | 6.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.6 | 4.8 | GO:0004962 | endothelin receptor activity(GO:0004962) |
1.5 | 6.0 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
1.4 | 2.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.4 | 5.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.4 | 5.7 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
1.4 | 1.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) interleukin-1, Type II, blocking receptor activity(GO:0004910) |
1.4 | 1.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.3 | 5.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.3 | 19.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.3 | 5.1 | GO:0061714 | folic acid receptor activity(GO:0061714) |
1.3 | 5.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.3 | 1.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.2 | 7.4 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
1.2 | 20.9 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
1.2 | 10.9 | GO:1903136 | cuprous ion binding(GO:1903136) |
1.2 | 11.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.2 | 2.3 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
1.2 | 3.5 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
1.2 | 4.7 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
1.1 | 10.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.1 | 19.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.1 | 2.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.1 | 7.6 | GO:0097643 | amylin receptor activity(GO:0097643) |
1.1 | 3.2 | GO:0086079 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
1.1 | 5.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
1.1 | 3.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.1 | 3.2 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
1.0 | 3.1 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
1.0 | 12.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.0 | 3.1 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
1.0 | 3.0 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
1.0 | 1.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
1.0 | 4.9 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
1.0 | 20.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.0 | 3.9 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
1.0 | 5.8 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.0 | 2.9 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.9 | 29.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.9 | 4.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.9 | 2.8 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.9 | 4.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.9 | 9.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.9 | 9.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.9 | 7.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.9 | 2.7 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.9 | 2.7 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.9 | 3.6 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.9 | 8.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.9 | 13.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.9 | 3.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.9 | 15.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.9 | 26.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.8 | 0.8 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.8 | 3.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.8 | 2.4 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.8 | 2.4 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.8 | 2.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 3.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.8 | 2.4 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.8 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.8 | 1.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.8 | 5.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.8 | 7.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.8 | 4.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.8 | 9.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.8 | 7.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.8 | 2.3 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.8 | 6.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.7 | 4.5 | GO:1902444 | riboflavin binding(GO:1902444) |
0.7 | 5.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.7 | 23.1 | GO:0031005 | filamin binding(GO:0031005) |
0.7 | 3.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.7 | 5.1 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.7 | 1.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.7 | 3.6 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.7 | 2.2 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.7 | 7.9 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.7 | 5.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 18.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.7 | 7.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.7 | 4.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.7 | 2.1 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.7 | 10.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.7 | 3.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.7 | 13.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 4.1 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.7 | 2.8 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.7 | 4.1 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.7 | 2.0 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.7 | 6.1 | GO:0042835 | BRE binding(GO:0042835) |
0.7 | 25.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.7 | 12.8 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.7 | 13.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.7 | 12.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 2.0 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.7 | 10.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.7 | 0.7 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.7 | 8.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 2.0 | GO:0036393 | thiocyanate peroxidase activity(GO:0036393) |
0.6 | 1.9 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.6 | 1.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.6 | 4.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 1.9 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.6 | 2.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.6 | 2.5 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.6 | 1.9 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.6 | 5.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 0.6 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.6 | 0.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.6 | 1.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.6 | 2.4 | GO:0005018 | platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.6 | 3.7 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.6 | 3.0 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.6 | 2.4 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.6 | 2.4 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.6 | 5.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.6 | 1.8 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.6 | 2.4 | GO:1990175 | EH domain binding(GO:1990175) |
0.6 | 0.6 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.6 | 5.4 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.6 | 1.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.6 | 5.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.6 | 16.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.6 | 3.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.6 | 2.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.6 | 2.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.6 | 6.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 1.7 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.6 | 2.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.6 | 0.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.6 | 3.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.6 | 1.7 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.6 | 7.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 2.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.6 | 1.7 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.6 | 3.9 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.5 | 6.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.5 | 2.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.5 | 4.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 9.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.5 | 2.7 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.5 | 4.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 2.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 0.5 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.5 | 1.6 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.5 | 6.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 2.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 1.5 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.5 | 6.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.5 | 2.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 5.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 5.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 1.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.5 | 3.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 9.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 0.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.5 | 4.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 2.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 1.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 3.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 3.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 2.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 3.8 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.5 | 16.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.5 | 1.4 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.5 | 1.9 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.5 | 1.9 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.5 | 1.8 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.5 | 4.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.5 | 12.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.5 | 2.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 5.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 10.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 10.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 4.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 1.3 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.4 | 4.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 2.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.4 | 2.6 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
0.4 | 21.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 2.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 2.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.4 | 1.7 | GO:1904492 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
0.4 | 18.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 5.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 8.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 2.1 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.4 | 3.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.4 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 7.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.4 | 4.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 2.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 1.2 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
0.4 | 2.0 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.4 | 12.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 1.2 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.4 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 1.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.4 | 2.8 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.4 | 7.5 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.4 | 1.2 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.4 | 5.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 22.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.2 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.4 | 3.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.4 | 1.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.4 | 1.1 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.4 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.4 | 2.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.4 | 2.2 | GO:0052847 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.4 | 2.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.4 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 3.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 2.5 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.4 | 1.1 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.4 | 1.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.4 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 2.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 33.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 8.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 19.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 1.7 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.3 | 14.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.3 | 1.0 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.3 | 2.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.3 | 7.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 1.0 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.3 | 1.7 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.3 | 2.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.3 | 1.0 | GO:0015039 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.3 | 1.0 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
0.3 | 6.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 2.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 2.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.3 | 3.0 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.3 | 2.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.3 | GO:0043532 | angiostatin binding(GO:0043532) |
0.3 | 0.6 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.3 | 1.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.3 | 1.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.3 | 1.6 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.3 | 18.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 0.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 13.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 2.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 8.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 12.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 4.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 9.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 17.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 4.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 7.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 9.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 1.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.3 | 1.2 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.3 | 4.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 0.6 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 57.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 0.9 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.3 | 2.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 0.9 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 3.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 1.1 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.3 | 1.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 2.0 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.3 | 5.1 | GO:0008061 | chitin binding(GO:0008061) |
0.3 | 2.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 1.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 6.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 3.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 29.6 | GO:0005254 | chloride channel activity(GO:0005254) |
0.3 | 4.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 0.8 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.3 | 3.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 3.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 1.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 2.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.3 | 1.1 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.3 | 3.4 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.3 | 3.4 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.3 | 2.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 3.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 4.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 1.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 0.8 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.3 | 0.5 | GO:1903135 | cupric ion binding(GO:1903135) |
0.2 | 1.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 1.5 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 1.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 7.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.7 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.2 | 8.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 2.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 4.6 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 3.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 2.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.2 | 1.2 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.2 | 1.4 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 0.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 4.1 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 2.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 12.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.9 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.2 | 0.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 5.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.9 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 3.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 5.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 2.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 3.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 2.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 6.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 2.2 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.2 | 2.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 0.7 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.2 | 4.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 1.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 16.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 2.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.5 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.2 | 0.6 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.2 | 16.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 1.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.3 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.2 | 3.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 4.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 1.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.8 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.2 | 1.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 1.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.0 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 1.6 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 0.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 3.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 2.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 33.5 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 21.3 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 24.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 1.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 1.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.8 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
0.2 | 3.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 1.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 4.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 0.9 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 8.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 3.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.9 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.2 | 3.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 1.5 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 5.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 1.3 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.2 | 2.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.2 | 0.5 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.2 | 0.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 4.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.9 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.2 | 1.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 0.4 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 1.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 10.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 5.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.2 | 1.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 1.0 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.2 | 1.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 2.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.7 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 0.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 1.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.2 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 0.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.2 | 0.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 3.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.7 | GO:0030305 | heparanase activity(GO:0030305) |
0.2 | 0.5 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.2 | 1.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 1.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.3 | GO:0032427 | GBD domain binding(GO:0032427) |
0.2 | 1.9 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 1.0 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.2 | 10.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 1.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 0.5 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.2 | 0.3 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.2 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 1.7 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.2 | 21.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 7.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 4.8 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.5 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.2 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 2.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 0.8 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.1 | 1.9 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 1.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 5.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 1.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 5.0 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.4 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.1 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.8 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 1.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 3.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 1.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.1 | 0.8 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 1.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.3 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.1 | 1.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 4.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.4 | GO:0032093 | SAM domain binding(GO:0032093) |
0.1 | 6.0 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 1.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 5.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.5 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.1 | 0.4 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
0.1 | 1.0 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.6 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.1 | 39.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.5 | GO:0015563 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
0.1 | 1.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 1.5 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 3.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 2.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 5.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.8 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.1 | 8.3 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 2.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.7 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 0.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 7.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.3 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.1 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 2.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 1.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.5 | GO:0035276 | ethanol binding(GO:0035276) |
0.1 | 0.1 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.5 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 1.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.8 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.8 | GO:0000828 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 1.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.1 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.1 | 2.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 9.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 1.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 1.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
0.1 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 1.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 1.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.4 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.1 | 0.5 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 0.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 2.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 2.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 2.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.3 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.6 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 0.6 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.3 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.3 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.4 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.3 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.1 | 1.5 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.7 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 1.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 1.0 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 2.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 6.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.2 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.1 | 0.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.1 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.1 | 0.2 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 1.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.8 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 58.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 16.0 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 1.5 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.2 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.1 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.3 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.1 | 2.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 1.0 | GO:0003909 | DNA ligase activity(GO:0003909) |
0.1 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.1 | GO:0030395 | lactose binding(GO:0030395) |
0.1 | 2.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 2.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.1 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.2 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 2.8 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 4.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.2 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.1 | 0.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.1 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.1 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 2.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 10.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.1 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.1 | 0.2 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.2 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
0.1 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 3.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 2.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.2 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.0 | 0.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 1.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.0 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.2 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.0 | 0.1 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.0 | 0.9 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.7 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.6 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.6 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.9 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.0 | 0.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 1.6 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 1.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 1.4 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.0 | 2.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 6.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0004057 | arginyltransferase activity(GO:0004057) |
0.0 | 2.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
0.0 | 0.5 | GO:0042277 | peptide binding(GO:0042277) |
0.0 | 0.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.0 | 0.1 | GO:0008892 | guanine deaminase activity(GO:0008892) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0033677 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0017129 | triglyceride binding(GO:0017129) |
0.0 | 0.1 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.0 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.3 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.0 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.0 | 3.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 3.1 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 8.1 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.0 | 0.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.0 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 0.4 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.4 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.1 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 3.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.0 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.0 | 1.0 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.0 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
0.0 | 0.0 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.0 | 0.0 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 21.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.7 | 51.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.7 | 2.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 13.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 33.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 2.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 23.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.4 | 0.9 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 4.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 4.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 13.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 10.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 1.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 20.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 16.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 23.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 9.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.3 | 8.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 7.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 11.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 8.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 20.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 2.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 93.5 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.3 | 14.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 6.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 1.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 9.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 18.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 6.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 18.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 3.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 5.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 4.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 12.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 7.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 2.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 2.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 10.4 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 3.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 4.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 4.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 6.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 10.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 3.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 12.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 4.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 3.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 2.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 39.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 8.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 5.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 8.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 6.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 4.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 3.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 6.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 2.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 2.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 3.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 3.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 33.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 4.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 3.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 2.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.6 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 39.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.0 | 4.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.9 | 22.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.8 | 34.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 2.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.7 | 1.4 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.7 | 15.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 10.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.6 | 18.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.6 | 1.7 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.6 | 0.6 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.5 | 36.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 3.0 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
0.5 | 12.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.5 | 8.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.5 | 35.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.4 | 12.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 7.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.4 | 12.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 16.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 20.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 8.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 10.7 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.4 | 24.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.4 | 19.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 20.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 4.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 2.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 23.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 4.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 19.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 21.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 7.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 7.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 12.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 5.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 3.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 5.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 2.3 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.3 | 17.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 10.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 16.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 1.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 9.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 4.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 10.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 3.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 4.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 22.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 8.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 2.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 0.4 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.2 | 7.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 2.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.2 | 4.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 5.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 4.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 7.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 3.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.8 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 2.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 6.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 3.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 9.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 13.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 6.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 2.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 25.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 4.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 8.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 3.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 2.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 3.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 3.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 1.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 2.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 2.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 2.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 1.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.3 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.0 | 1.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 4.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 1.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 1.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 1.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 2.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 4.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.9 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.0 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 2.5 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 1.6 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 5.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.1 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |